🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical trial is to find out whether one type of fish ...
Status
Not Yet Recruiting
Location
Institut de recherches cliniques de Montréal (IRCM)
Start Date
2026-07
Trial ID
NCT07575438
Treatments Being Tested
Incretin mimetics are widely used pharmacological treatments for weight los...
Status
Recruiting
Location
Cantonal Hospital Aarau
Start Date
2025-03-15
Trial ID
NCT06856291
In the unfortunate case of severe hypoglycaemia, glucagon is the first-line...
Status
Withdrawn
Location
Institut de recherches cliniques de Montréal
Start Date
2013-04
Trial ID
NCT01828125
Treatments Being Tested
Previous studies have demonstrated defects in the trafficking and transloca...
Status
Completed
Location
Centre de recherche en nutrition humaine Rhone-Alpes
Start Date
2012-06
Trial ID
NCT01648478
Treatments Being Tested
This study tests the hypothesis that, compared to prior normal blood sugar,...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2013-07-17
Trial ID
NCT03429946
Treatments Being Tested
Obesity is an independent risk factor for type 2 diabetes and cardiovascula...
Status
Unknown
Location
University of Virginia
Start Date
2019-02-18
Trial ID
NCT03894527
Treatments Being Tested
The purpose of this experimental study is to investigate whether an acute l...
Status
Completed
Location
Department of Medicine, Division of Endocrinology, St. Olavs Hospital
Start Date
2004-01
Trial ID
NCT00829569
Treatments Being Tested
Preclinical studies have demonstrated in mouse models that (PYR1)-apelin-13...
Status
Completed
Location
University Hospitals of Toulouse (Rangueil)
Start Date
2016-05
Trial ID
NCT02724566
This study investigates the potential of vericiguat, a soluble guanylate cy...
Status
Not Yet Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-12-01
Trial ID
NCT06320951
Dapagliflozin is a highly selective, reversible and potent inhibitor of the...
Status
Completed
Location
Medical University Innsbruck, Department of Internal Medicine I
Start Date
2014-08
Trial ID
NCT02211742
Treatments Being Tested